Product Code: ETC6185320 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market is witnessing a rise in demand as MIGS techniques offer a safer and more efficient alternative to traditional glaucoma surgeries. MIGS devices are designed to lower intraocular pressure in glaucoma patients with minimal risk and faster recovery. As the incidence of glaucoma rises with an aging population, the MIGS market continues to grow, supported by advancements in device technology and clinical research. Additionally, MIGS surgeries are often performed in outpatient settings, reducing hospital costs and increasing their appeal to both healthcare providers and patients.
In Australia, the Minimally Invasive Glaucoma Surgery (MIGS) devices market is poised for significant growth as more patients seek alternatives to traditional glaucoma surgery. MIGS devices offer reduced recovery times, fewer complications, and improved patient outcomes compared to conventional surgical techniques. The increasing prevalence of glaucoma, along with the growing demand for less invasive treatment options, is driving this market. Additionally, technological advancements in MIGS devices, including enhanced precision and improved ease of use, are expected to further fuel market expansion.
The minimally invasive glaucoma surgery (MIGS) devices market in Australia is confronted with the challenge of balancing cost and accessibility. MIGS devices are often more expensive compared to traditional surgery, which can make them less accessible to patients, especially in the public healthcare system. Additionally, there is the challenge of educating ophthalmologists about these advanced procedures, which can impact the adoption rate. Regulatory approval timelines can also be long, hindering the rapid availability of new devices.
The Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices market presents investment opportunities in the field of glaucoma treatment, where minimally invasive techniques are becoming increasingly popular due to their lower risk of complications and faster recovery times. MIGS devices, such as stents and micro-incisional surgeries, allow for effective pressure management in the eye without the need for traditional surgeries. Investing in developing more effective MIGS devices, particularly those with longer-lasting results and reduced side effects, could provide substantial returns. Additionally, expanding access to MIGS procedures through healthcare partnerships and improving device affordability could help capture a larger share of the growing patient base.
Australia regulatory and reimbursement landscape supports the growth of the minimally invasive glaucoma surgery (MIGS) device market. Medicare reimbursements for MIGS procedures help increase their accessibility, promoting wider adoption of these devices in clinical settings. The TGA ensures that all MIGS devices undergo stringent evaluation processes to meet safety and performance standards. Moreover, the Australia governments focus on advancing medical technology through funding programs such as the MRFF supports ongoing innovation in glaucoma treatments, including MIGS.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market - Industry Life Cycle |
3.4 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market - Porter's Five Forces |
3.5 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume Share, By Surgery, 2021 & 2031F |
3.6 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume Share, By Target, 2021 & 2031F |
3.7 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.8 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of glaucoma in Australia |
4.2.2 Growing adoption of minimally invasive surgical techniques |
4.2.3 Technological advancements in MIGS devices |
4.3 Market Restraints |
4.3.1 High cost associated with MIGS devices |
4.3.2 Limited reimbursement policies for minimally invasive glaucoma surgery |
4.3.3 Lack of skilled professionals for performing MIGS procedures |
5 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Trends |
6 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market, By Types |
6.1 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market, By Surgery |
6.1.1 Overview and Analysis |
6.1.2 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By Surgery, 2021- 2031F |
6.1.3 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By Glaucoma in Conjunction with Cataract, 2021- 2031F |
6.1.4 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By Stand Alone Glaucoma, 2021- 2031F |
6.2 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market, By Target |
6.2.1 Overview and Analysis |
6.2.2 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By Trabecular Meshwork, 2021- 2031F |
6.2.3 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By Suprachoroidal Space, 2021- 2031F |
6.2.4 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market, By Product |
6.3.1 Overview and Analysis |
6.3.2 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By MIGS Stents, 2021- 2031F |
6.3.3 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By MIGS Shunts, 2021- 2031F |
6.3.4 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By Eye Hospitals, 2021- 2031F |
6.4.3 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By Ophthalmology Clinics, 2021- 2031F |
6.4.4 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenues & Volume, By Outpatient Surgical Centers, 2021- 2031F |
7 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Import-Export Trade Statistics |
7.1 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Export to Major Countries |
7.2 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Imports from Major Countries |
8 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Key Performance Indicators |
8.1 Number of ophthalmologists trained in minimally invasive glaucoma surgery techniques |
8.2 Rate of adoption of MIGS devices in Australian hospitals and clinics |
8.3 Patient satisfaction scores post MIGS procedures |
8.4 Number of clinical trials or studies on the effectiveness of MIGS devices in Australia |
8.5 Percentage of glaucoma surgeries performed using minimally invasive techniques |
9 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market - Opportunity Assessment |
9.1 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Opportunity Assessment, By Surgery, 2021 & 2031F |
9.2 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Opportunity Assessment, By Target, 2021 & 2031F |
9.3 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.4 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market - Competitive Landscape |
10.1 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Revenue Share, By Companies, 2024 |
10.2 Australia Minimally Invasive Slaucoma Surgery MIGS Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |